Inovio Pharmaceuticals Inc (NASDAQ:INO)

10.04
Delayed Data
As of Apr 17
 -0.285 / -2.76%
Today’s Change
6.33
Today|||52-Week Range
14.20
+9.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues2.4M3.2M1.2M2.5M
 
 
 
 
 
Depreciation And Amortization355.3K366.3K419.3K428.4K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.0M13.6M9.8M13.0M
 
 
 
 
 
Research And Development8.2M9.6M7.0M9.2M
 
 
 
 
 
Total Operating Expenses12.4M14.0M10.2M13.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.0M-10.7M-8.9M-11.0M
 
 
 
 
 
Extraordinary Credit--824.4K--3.5M
 
 
 
Extraordinary Charge-505.9K0.00-114.0K--
 
 
 
Pre-Tax Equity Earnings-377.0K-1.5M1.2M--
 
 
 
 
Other Expenses0.00556.4K610.9K113.2K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.8M-10.7M-7.2M-7.4M
 
 
 
 
 
Minority Interest-9.4K-6.4K-1.5K-1.1K
 
 
 
 
 
Net Income-10.8M-10.7M-7.2M-7.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.2M60.2M60.4M60.6M
 
 
 
 
 
Shares To Calculate EPS Diluted55.2M60.2M60.6M60.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.19-$0.12-$0.12
 
 
 
 
 
EPS Diluted-$0.20-$0.18-$0.12-$0.12
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account